Revenue

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
BioSolutions Revenue	4.39B	4.24B	Log In	Log In	Log In	Upgrade
BioMaterials Revenue	2.63B	2.62B	Log In	Log In	Log In	Upgrade
Fine Chemicals Revenue	652.00M	799.00M	Log In	Log In	Log In	Upgrade
Eliminations From Revenue	-45.00M	-45.00M	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Norway Revenue	227.00M	Log In	Log In	Log In	Upgrade
Rest of Europe Revenue	3.25B	Log In	Log In	Log In	Upgrade
Asia Revenue	1.72B	Log In	Log In	Log In	Upgrade
America Revenue	2.24B	Log In	Log In	Log In	Upgrade
Rest of World Revenue	60.00M	Log In	Log In	Log In	Upgrade
Other Operating Revenue	115.00M	Log In	Log In	Log In	Upgrade

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
BioSolutions EBITDA	1.22B	1.10B	Log In	Log In	Log In	Upgrade
BioMaterials EBITDA	470.00M	434.00M	Log In	Log In	Log In	Upgrade
Fine Chemicals EBITDA	186.00M	336.00M	Log In	Log In	Log In	Upgrade

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
BioSolutions Operating Profit	888.00M	791.00M	Log In	Log In	Log In	Upgrade
BioMaterials Operating Profit	226.00M	200.00M	Log In	Log In	Log In	Upgrade
Fine Chemicals Operating Profit	140.00M	292.00M	Log In	Log In	Log In	Upgrade

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
BioSolutions - Gross Average Sales Price per MTDS	-	12.05K	Log In	Log In	Log In	Upgrade
BioSolutions - Specialities Sales Volume (MTDS in Thousands)	-	85.00	Log In	Log In	Log In	Upgrade
BioSolutions - Contruction Sales Volume (MTDS in Thousands)	-	97.00	Log In	Log In	Log In	Upgrade
BioSolutions - Industrial Sales Volume (MTDS in Thousands)	-	145.00	Log In	Log In	Log In	Upgrade
BioSolutions - Total Sales Volume (MTDS in Thousands)	332.00	327.00	Log In	Log In	Log In	Upgrade
BioMaterials - Gross Average Sales Price per MT	-	16.34K	Log In	Log In	Log In	Upgrade
BioMaterials - Sales Volume (MT in Thousands)	144.80	159.90	Log In	Log In	Log In	Upgrade
High Specialised % of Total Cellulose Product Sales Volume	-	83.00%	Log In	Log In	Log In	Upgrade

Updated Sep 30, 2025. Data Source: Fiscal.ai.